Dalfampridine Prices, Coupons and Patient Assistance Programs
Dalfampridine is a member of the miscellaneous central nervous system agents drug class and is commonly used for Multiple Sclerosis.
Brand names for dalfampridine include Ampyra.
This dalfampridine price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for dalfampridine oral tablet, extended release 10 mg is around $1,998 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Oral Tablet, Extended Release
|60||$33.30 – $34.06||$1,998.25 – $2,043.33|
See brand name versions of this drug:
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Dalfampridine Coupons and Rebates
Dalfampridine offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Dalfampridine
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about dalfampridine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 61 Reviews
- Drug class: miscellaneous central nervous system agents
- FDA Alerts (1)
Other brands: Ampyra